Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.
Abdominal candidiasis
Candida
Candidemia
Candidiasis
ICU
Incidence
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
14 Jun 2019
14 Jun 2019
Historique:
received:
05
04
2019
accepted:
28
05
2019
entrez:
16
6
2019
pubmed:
16
6
2019
medline:
20
12
2019
Statut:
epublish
Résumé
The objective of this study was to assess the cumulative incidence of invasive candidiasis (IC) in intensive care units (ICUs) in Europe. A multinational, multicenter, retrospective study was conducted in 23 ICUs in 9 European countries, representing the first phase of the candidemia/intra-abdominal candidiasis in European ICU project (EUCANDICU). During the study period, 570 episodes of ICU-acquired IC were observed, with a cumulative incidence of 7.07 episodes per 1000 ICU admissions, with important between-center variability. Separated, non-mutually exclusive cumulative incidences of candidemia and IAC were 5.52 and 1.84 episodes per 1000 ICU admissions, respectively. Crude 30-day mortality was 42%. Age (odds ratio [OR] 1.04 per year, 95% CI 1.02-1.06, p < 0.001), severe hepatic failure (OR 3.25, 95% 1.31-8.08, p 0.011), SOFA score at the onset of IC (OR 1.11 per point, 95% CI 1.04-1.17, p 0.001), and septic shock (OR 2.12, 95% CI 1.24-3.63, p 0.006) were associated with increased 30-day mortality in a secondary, exploratory analysis. The cumulative incidence of IC in 23 European ICUs was 7.07 episodes per 1000 ICU admissions. Future in-depth analyses will allow explaining part of the observed between-center variability, with the ultimate aim of helping to improve local infection control and antifungal stewardship projects and interventions.
Sections du résumé
BACKGROUND
BACKGROUND
The objective of this study was to assess the cumulative incidence of invasive candidiasis (IC) in intensive care units (ICUs) in Europe.
METHODS
METHODS
A multinational, multicenter, retrospective study was conducted in 23 ICUs in 9 European countries, representing the first phase of the candidemia/intra-abdominal candidiasis in European ICU project (EUCANDICU).
RESULTS
RESULTS
During the study period, 570 episodes of ICU-acquired IC were observed, with a cumulative incidence of 7.07 episodes per 1000 ICU admissions, with important between-center variability. Separated, non-mutually exclusive cumulative incidences of candidemia and IAC were 5.52 and 1.84 episodes per 1000 ICU admissions, respectively. Crude 30-day mortality was 42%. Age (odds ratio [OR] 1.04 per year, 95% CI 1.02-1.06, p < 0.001), severe hepatic failure (OR 3.25, 95% 1.31-8.08, p 0.011), SOFA score at the onset of IC (OR 1.11 per point, 95% CI 1.04-1.17, p 0.001), and septic shock (OR 2.12, 95% CI 1.24-3.63, p 0.006) were associated with increased 30-day mortality in a secondary, exploratory analysis.
CONCLUSIONS
CONCLUSIONS
The cumulative incidence of IC in 23 European ICUs was 7.07 episodes per 1000 ICU admissions. Future in-depth analyses will allow explaining part of the observed between-center variability, with the ultimate aim of helping to improve local infection control and antifungal stewardship projects and interventions.
Identifiants
pubmed: 31200780
doi: 10.1186/s13054-019-2497-3
pii: 10.1186/s13054-019-2497-3
pmc: PMC6567430
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
219Références
Intensive Care Med. 2009 Jan;35(1):55-62
pubmed: 18972101
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S87-91
pubmed: 19013346
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Crit Care Med. 2011 Apr;39(4):665-70
pubmed: 21169817
Mycoses. 2012 Jan;55(1):73-9
pubmed: 21668521
Intensive Care Med. 2013 Dec;39(12):2092-106
pubmed: 24105327
Intensive Care Med. 2014 Jun;40(6):839-45
pubmed: 24807083
Intensive Care Med. 2015 Sep;41(9):1601-10
pubmed: 26077063
Ann Intensive Care. 2016 Dec;6(1):2
pubmed: 26743881
Crit Care. 2016 Mar 09;20:53
pubmed: 26956367
Intensive Care Med. 2017 Apr;43(4):509-518
pubmed: 28271321
J Infect. 2017 Jul;75(1):59-67
pubmed: 28366686